New trial tests if operating on Newborns' hearts within 28 days beats waiting months
NCT ID NCT06822400
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares two surgical timings for babies born with Tetralogy of Fallot, a serious heart defect. One group gets corrective surgery within 28 days of birth, the other at the usual 3-6 months. Researchers will track deaths, reoperations, and recovery to see if earlier surgery leads to better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
corrective heart surgery
What this could lead to
If early surgery works better, it could improve survival and long-term heart function for babies born with this serious heart defect.
What could go wrong
This is a relatively small trial (160 babies) and results may not apply to all hospitals. Surgery in newborns carries higher risks of complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETRALOGY OF FALLOT (TOF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital
RECRUITINGBeijing, Beijing Municipality, 100013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••